J Clin Microbiol 2001,39(10):3427–3436.CrossRefPubMed 2. Mahenthiralingam E, FHPI manufacturer Vandamme P: Taxonomy and pathogenesis of the Burkholderia cepacia complex. Chron Respir Dis 2005,2(4):209–217.CrossRefPubMed 3. Isles A, Maclusky I, Corey M, Gold R, Prober C, Fleming P, Levison H:Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984,104(2):206–210.CrossRefPubMed 4. Govan JR, Brown AR, Jones AM: Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection. Future Microbiol 2007, 2:153–164.CrossRefPubMed 5. Waters V, Ratjen F: Multidrug-resistant
organisms in cystic fibrosis: management and infection-control issues. Expert Rev Buparlisib chemical structure Anti Infect Ther 2006,4(5):807–819.CrossRefPubMed 6. Saiman L, Siegel J, Cystic Fibrosis Foundation: Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient
transmission. Infect Control Hosp Epidemiol 2003,24(Suppl 5):S6–52.CrossRefPubMed 7. Aronoff SC: Outer membrane permeability in Pseudomonas cepacia : diminished porin content in a beta-lactam-resistant mutant and in resistant cystic fibrosis isolates. Antimicrob Agents KU55933 chemical structure Chemother 1988,32(11):1636–1639.PubMed 8. Moore RA, Hancock RE: Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance. Antimicrob Agents Chemother 1986,30(6):923–926.PubMed 9. Parr TR Jr, Moore RA, Moore LV, Hancock RE: Role of porins in intrinsic antibiotic resistance of Pseudomonas cepacia. Antimicrob Agents Chemother 1987,31(1):121–123.PubMed 10. Trépanier S, Prince A, Huletsky A: Characterization of
the penA and penR genes of Burkholderia cepacia 249 which encode the chromosomal class A penicillinase and its LysR-type transcriptional regulator. Antimicrob Agents Chemother 1997,41(11):2399–2405.PubMed 11. Burns JL, Lien DM, Hedin Microbiology inhibitor LA: Isolation and characterization of dihydrofolate reductase from trimethoprim-susceptible and trimethoprim-resistant Pseudomonas cepacia. Antimicrob Agents Chemother 1989,33(8):1247–1251.PubMed 12. Burns JL, Wadsworth CD, Barry JJ, Goodall CP: Nucleotide sequence analysis of a gene from Burkholderia ( Pseudomonas ) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance. Antimicrob Agents Chemother 1996,40(2):307–313.PubMed 13. Fehlner-Gardiner CC, Valvano MA: Cloning and characterization of the Burkholderia vietnamiensis norM gene encoding a multi-drug efflux protein. FEMS Microbiol Lett 2002,215(2):279–283.CrossRefPubMed 14. Wigfield SM, Rigg GP, Kavari M, Webb AK, Matthews RC, Burnie JP: Identification of an immunodominant drug efflux pump in Burkholderia cepacia. J Antimicrob Chemother 2002,49(4):619–624.CrossRefPubMed 15. Poole K, Srikumar R: Multidrug efflux in Pseudomonas aeruginosa : components, mechanisms and clinical significance.
No related posts.